Consensus Guidelines on Management of Steroid-Resistant Nephrotic Syndrome

被引:0
作者
Anil Vasudevan
Ranjeet Thergaonkar
Mukta Mantan
Jyoti Sharma
Priyanka Khandelwal
Pankaj Hari
Aditi Sinha
Arvind Bagga
机构
[1] St. John’s Medical College Hospital,Department of Pediatric Nephrology
[2] INHS Asvini,Pediatric Nephrology Service
[3] Maulana Azad Medical College,Division of Nephrology, Department of Pediatrics
[4] King Edward Memorial Hospital,undefined
[5] All India Institute of Medical Sciences,undefined
来源
Indian Pediatrics | 2021年 / 58卷
关键词
Calcineurin inhibitors; Congenital nephrotic syndrome; Focal segmental glomerulosclerosis; Minimal change disease;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:650 / 666
页数:16
相关论文
共 370 条
[1]  
Noone DG(2018)Idiopathic nephrotic syndrome in children Lancet 392 61-74
[2]  
Iijima K(2018)Management of steroid-resistant nephrotic syndrome in children and adolescents Lancet Child Adolesc Health 2 880-90
[3]  
Parekh R(2011)Clinical trial of focal segmental glomerulosclerosis in children and young adults Kidney Int 80 868-78
[4]  
Tullus K(2005)Focal and segmental glomerulosclerosis: Definition and relevance of a partial remission J Am Soc Nephrol 16 1061-8
[5]  
Webb H(2009)Management of steroid resistant nephrotic syndrome Indian Pediatr 46 35-47
[6]  
Bagga A(2020)IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome Pediatr Nephrol 35 1529-61
[7]  
Gipson DS(2004)Classifying Recommendations for Clinical Practice Guidelines Pediatrics 114 874-7
[8]  
Trachtman H(1981)Identification of patients with minimal change nephrotic syndrome from initial response to prednisone: A report of the International Study of Kidney Disease in Children J Pediatr 98 561-4
[9]  
Kaskel FJ(2015)Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome Kidney Int 87 217-24
[10]  
Troyanov S(2013)Two-year outcome of the ISKDC regimen and frequent-relapsing risk in children with idiopathic nephrotic syndrome Clin J Am SocNephrol 8 756-62